Third Doses of Moderna are Now Available
As of 8/14/2021, we will be offering third doses of Moderna vaccine to eligible immunocompromised patients. You may receive a third dose from us regardless of where you receieved previous doses.
The current CDC, FDA and ACIP recommendation is that people with moderately and severely immunocompromising conditions should receive an additional (third) dose of COVID-19 vaccine as part of their primary series. These conditions include:
Active treatment for solid tumor and hematologic malignancies.
Receipt of solid-organ transplant and taking immunosuppressive therapy.
Receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy).
Moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes).
Advanced or untreated HIV infection.
Active treatment with high-dose corticosteroids (i.e., ≥20 mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, TNF (tumor necrosis factor) blockers, and other biologic agents that are immunosuppressive or immunomodulatory.
Please call us if you have any questions about these eligibility criteria.
We are currently offering Moderna vaccines on a walk in basis. You may call or text us at 763-441-1353 if you prefer to schedule an appointment.
Please note, Pfizer BioNTech can be administered to people 12 years and older and Moderna for people 18 years and older. We ONLY Have Moderna available. It is recommended that you get the same vaccine for the third dose as you received for the previous two doses. The third dose can not be administered sooner than 28 days following the second dose.
This additional dose recommendation is intended to provide added assurance of a response to vaccination. It is likely that even with an additional dose in the series, those that are moderately to severely immunocompromised will need to continue to take measures to reduce the risk of exposure to COVID-19.
Immunocompromised people, including those who receive an additional mRNA dose, need to continue to follow prevention measures, which include:
Wear a mask.
Stay 6 feet apart from those you don’t live with.
Avoid crowds and poorly ventilated indoor spaces until advised otherwise by your health care provider.
Close contacts of immunocompromised people are strongly urged to get vaccinated against COVID-19, wear a mask in public indoor settings in areas of substantial or high transmission (refer to CDC COVID Data Tracker), wear a mask if they have been exposed to an infected person, and test 3-5 days after exposure to an infected person.